SAN FRANCISCO, Oct. 29 – Celera Genomics will include GeneFormatics’ structural proteomics database in its Discovery System, the companies announced Monday.

San Diego, Calif.-based GeneFormatics’ Proteomics Database contains approximately 7,000 novel biochemical function and structure assignments for potential drug targets in humans, according to the company.

Financial details of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.